Аутоиммунная некротизирующая статин-индуцированная миопатия

A. B. Sumarokov

doi:10.34687/2219-8202.JAD.2022.02.0001

Authors

A. B. Sumarokov Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CENTER OF CARDIOLOGY NAMED AFTER ACADEMICIAN E.I.CHAZOV

DOI:

https://doi.org/10.34687/2219-8202.JAD.2022.02.0001

Keywords:

Statins. Side effects. Autoimmune necrotizing myopathy

Abstract

Statin-Induced Autoimmune Myopathy is a very rare complication of lipid-lowering therapy with statins. This pathology distinguished from other myopathy forms and described during last years. Review of types statin-induced autoimmune myopathy is presented

Downloads

Download data is not yet available.

References

Alfirevic A, Neely D, Armitage J et al, Phenotype standardization for statin-induced myotoxicity., Clin Pharm Ther.2014; 96: 470-476 10.1038/clpt.2014.121 2. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011; 63(3):713-21. https://doi.org/10.1002/art.30156

Basharat P, Christopher-Stine L., Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management, Curr Rheumatol Rep, 2015; 17(12): 72-78., DOI 10.1007/s11926-015-0548-6

Day JA, Limaye V., Immune-mediated necrosing myopathy: A critical review of current concepts., Seminars in Arthritis and Rheumatism 2019, 49: 420-429 https://doi.org/10.1016/j.semarthrit.2019.04.002

Tiniacou E. Statin -Associated Autoimmune Myopathy: Current Perspectives., Therapeutics and Clinical Risk Management, 2020:16 483-492., https://doi.org10.2147/TCRM.S197941

Mohassel P, Mammen AL, Anti-HMGCR Myopathy., J Neuromascular Diseases 2018, 5:11-20 Doi.10.3233/JND-17028211.

Babu S, Li Y., Statin-Induced Autoimmune Myopathy., J of Neurological Sciences,2015, 351, 13-17., https://doi.org/10.1016/j.jns. 2015.02.042

Kurashige T., Anti-HMGCR myopathy: clinical and histopatological features, and prognosis., Curr Opin Rheumatol, 2021, 33: 554-562., DOI:10.1097/BOR.0000000000000832

Mc Grath ER, Doughty CT, Amato AA., Autoimmune Myopathies: Updates on Evaluation and Treatment, Neurotherapeutics, 2018; 15: 976-994, doi.org/10/s13311-018-00676-2

Senecal J-L, Raynauld J-P, Troyanov Y. A New classification of Adult Autoimmune Myositis., Amer College of Rheumatology 2017, 69 (5), 878-884., DOI 10.1002/art.40063.

Borges IBP, Silva MG, Misse RG, Shinjo SK., Lipid-Lowering agent triggered dermatomyositis and polimyositis: a case series and literature review.,

Rheumatol Int 2018; 38: 293-301., https://org/10.1007/s00296-017-3821-3

Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve. 2010 Feb;41(2):185-90. doi: 10.1002/mus.21486. PMID: 19813188.

Ma X, Xu L, Li Y, Bu B., The Clinicopathological Distinction Between Seropositive and Seropositive Immune Necrotizing Myopathy in China. Frontiers in Neurology, 2021, V 12, article 670784., doi: 10.3389/fneur.2021.6707845.

Pinal-Fernandes I, Casal-Dominguez M, Mammen AL., Immune-Mediated Necrotizing Myopathy. Current Rheumatology Reports, 2018, 20: 21 https://doi.org/10.1007/s11926-018-0732-6

Kassargian CD, Lennon VA, Alfugham NB, et al, Clinical features and Treatment Outcomes of Necrotizing Autoimmune Myopathy., JAMA Neurol, 2015; 72(9), 996-1003. doi.10.1001/jamaneurol.2015.1207

Ashton C, Junkestarff R, Bundell C, Hollingworth P, Needham P, Treatment and outcomes in necrotizing autoimmune myopathy: an Australian perspective.

Neuromuscular Disorders, 2016, 26,734-740., https://dx.doi.org/10.1016/j/nmd.2016.08.013

Irvine NJ., Anti- HMGCR Myopathy: A Rare and Serious Side Effects of Statins., J Am Board Fam Med., 2020; 33(5):785-789., doi:10.3122/jabfm.2020.05.190450

Abusharar SP, Moku P, Banks S, Khalid FM, Specht CS, Polimera HV., Immune mediated necrotizing myopathy: A rare complication of statin therapy., Clinics and Practice 2020; 10:1248. doi:10.4081/cp.2020.1248

Gawey B, Tannu M, Rim J, Sperling L, Henry TL., Statin-Induced Necrotizing Autoimmune Myopathy., JACC Case Reports, 2020, 2(3):440-443., doi.org/10.1016/j.jaccas.2019.12.019

Paul M, Paul P, Dey D, Moazzem SW, Shamrin F., A Case of Statin-Associated Immune - Mediated Necrotizing Myopathy, Succesfully Treated With Intravenous Immunoglobullin., Cureus 13(6): e16001, DOI 10.7759/cureus.16001

Aimal M, Singh A, Kubba S, Hershman M, Acharya T., Statin-Induced Triad of Autoimmune Myocarditis, Myositis, Transaminitis., Case Reports in Cardiology, 2021, Article 6660362., https://doi.org/10.1155/2021/6660362

Jayatilaka S, Desai K, Rijal S, Zimmermann D., Statin-Induced Autoimmune Necrotizing Myopathy., J of Primary Care & Community Health., 2021, 12, 1-3., DOI:101177/2150132721 1028714

Nemati M, Srai M, Rudrangi R., Statin-Induced Autoimmune Myopathy.,2021, Cureus 13(2):e13576. DOI 10.7759/cureus.13576